{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:11:57Z","timestamp":1762503117413,"version":"build-2065373602"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T00:00:00Z","timestamp":1638748800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.ctro.2021.12.002","type":"journal-article","created":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T02:18:09Z","timestamp":1639621089000},"page":"23-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["The impact of red blood cell transfusion on mortality and treatment efficacy in patients treated with radiation: A systematic review"],"prefix":"10.1016","volume":"33","author":[{"given":"Max","family":"Deschner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lakshman","family":"Vasanthamohan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sondos","family":"Zayed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Lazo-Langner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Palma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"D'Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed","family":"Omar Gilani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Gabriel Boldt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziad","family":"Solh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctro.2021.12.002_b0005","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0360-3016(01)01662-5","article-title":"Tumor size and oxygenation are independent predictors of nodal diseases in patients with cervix cancer","volume":"51","author":"Pitson","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2021.12.002_b0010","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1080\/09553000601002324","article-title":"Hypoxia: importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy","volume":"82","author":"Tatum","year":"2006","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.ctro.2021.12.002_b0015","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJM199902113400601","article-title":"A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group","volume":"340","author":"Hebert","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ctro.2021.12.002_b0020","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1182\/blood.V128.22.1032.1032","article-title":"Transfusion of Red Cells in Hematopoietic Stem Cell Transplantation (TRIST Study): A Randomized Controlled Trial Evaluating 2 Red Cell Transfusion Thresholds","volume":"128","author":"Tay","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.ctro.2021.12.002_b0025","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ahj.2018.04.007","article-title":"Clinical trials evaluating red blood cell transfusion thresholds: An updated systematic review and with additional focus on patients with cardiovascular disease","volume":"200","author":"Carson","year":"2018","journal-title":"Am Heart J"},{"key":"10.1016\/j.ctro.2021.12.002_b0030","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1001\/jama.2019.0554","article-title":"Patient Blood Management: Recommendations From the 2018 Frankfurt Consensus Conference","volume":"321","author":"Mueller","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.ctro.2021.12.002_b0035","doi-asserted-by":"crossref","first-page":"h1354","DOI":"10.1136\/bmj.h1354","article-title":"Restrictive versus liberal transfusion strategy for red blood cell transfusion: systematic review of randomised trials with meta-analysis and trial sequential analysis","volume":"350","author":"Holst","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.ctro.2021.12.002_b0040","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ijrobp.2005.04.049","article-title":"Anemia, tumor hypoxemia, and the cancer patient","volume":"63","author":"Varlotto","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2021.12.002_b0045","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1749-4486.2007.01544.x","article-title":"Clinical and biological factors affecting response to radiotherapy in patients with head and neck cancer: a review","volume":"32","author":"Silva","year":"2007","journal-title":"Clin Otolaryngol"},{"key":"10.1016\/j.ctro.2021.12.002_b0050","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.ijrobp.2004.07.710","article-title":"Pretreatment anemia is correlated with the reduced effectiveness of radiation and concurrent chemotherapy in advanced head and neck cancer","volume":"61","author":"Prosnitz","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2021.12.002_b0055","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.3109\/0284186X.2011.592650","article-title":"Does transfusion improve the outcome for HNSCC patients treated with radiotherapy? - results from the randomized DAHANCA 5 and 7 trials","volume":"50","author":"Hoff","year":"2011","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ctro.2021.12.002_b0060","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/(SICI)1097-0142(19991015)86:8<1528::AID-CNCR20>3.0.CO;2-E","article-title":"The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix","volume":"86","author":"Grogan","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.ctro.2021.12.002_b0065","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0360-3016(02)02896-1","article-title":"Evaluation of the effect of routine packed red blood cell transfusion in anemic cervix cancer patients treated with radical radiotherapy","volume":"54","author":"Kapp","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2021.12.002_b0070","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0360-3016(89)90007-2","article-title":"Prognostic value of hemoglobin concentrations and blood transfusions in advanced carcinoma of the cervix treated by radiation therapy: results of a retrospective study of 386 patients","volume":"16","author":"Girinski","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2021.12.002_b0075","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000072328","article-title":"Influence of allogeneic blood transfusion on clinical outcome during radiotherapy for cancer of the uterine cervix","volume":"56","author":"Santin","year":"2003","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.ctro.2021.12.002_b0080","doi-asserted-by":"crossref","first-page":"993","DOI":"10.3349\/ymj.2008.49.6.993","article-title":"Allogeneic blood transfusion given before radiotherapy is associated with the poor clinical outcome in patients with cervical cancer","volume":"49","author":"Lim","year":"2008","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.ctro.2021.12.002_b0085","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/01.coc.0000264177.66369.18","article-title":"Prognostic significance of blood transfusions in patients with esophageal cancer treated with combined chemoradiotherapy","volume":"30","author":"Kader","year":"2007","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ctro.2021.12.002_b0090","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ijrobp.2008.04.052","article-title":"Anemia during sequential induction chemotherapy and chemoradiation for head and neck cancer: the impact of blood transfusion on treatment outcome","volume":"73","author":"Bhide","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2021.12.002_b0095","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s13566-014-0145-8","article-title":"Prognostic significance of blood transfusion and anaemia on survival in stage IIIA\/B\/C and IVA oesophageal cancers treated with chemoradiotherapy","volume":"3","author":"Tuan","year":"2014","journal-title":"J Radiat Oncol"},{"key":"10.1016\/j.ctro.2021.12.002_b0100","first-page":"116","article-title":"Effect of blood transfusion on survival after radiotherapy as treatment for carcinoma of the prostate","volume":"73","author":"Davies","year":"1991","journal-title":"Ann R Coll Surg Engl"},{"key":"10.1016\/j.ctro.2021.12.002_b0105","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/(SICI)1096-911X(199905)32:5<395::AID-MPO18>3.0.CO;2-C","article-title":"Effect of hemoglobin on radiotherapy response in children with medulloblastoma: should patients with a low hemoglobin be transfused?","volume":"32","author":"Chow","year":"1999","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.ctro.2021.12.002_b0110","doi-asserted-by":"crossref","first-page":"536","DOI":"10.6004\/jnccn.2008.0042","article-title":"Cancer- and chemotherapy-induced anemia","volume":"6","author":"Rodgers","year":"2008","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.ctro.2021.12.002_b0115","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1211801","article-title":"Transfusion strategies for acute upper gastrointestinal bleeding","volume":"368","author":"Villanueva","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ctro.2021.12.002_b0120","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ijrobp.2014.09.023","article-title":"Relationship between low hemoglobin levels and outcomes after treatment with radiation or chemoradiation in patients with cervical cancer: has the impact of anemia been overstated?","volume":"91","author":"Bishop","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2021.12.002_b0125","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/IGC.0000000000000902","article-title":"Impact of Blood Transfusions on Survival of Locally Advanced Cervical Cancer Patients Undergoing Neoadjuvant Chemotherapy Plus Radical Surgery","volume":"27","author":"Bogani","year":"2017","journal-title":"Int J Gynecol Cancer"},{"issue":"Suppl 5","key":"10.1016\/j.ctro.2021.12.002_b0130","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1634\/theoncologist.9-90005-31","article-title":"Hypoxia and anemia: factors in decreased sensitivity to radiation therapy and chemotherapy?","volume":"9","author":"Harrison","year":"2004","journal-title":"Oncologist"},{"key":"10.1016\/j.ctro.2021.12.002_b0135","first-page":"20170955","article-title":"Tumor oxygenation and cancer therapy-then and now","volume":"92","author":"Hughes","year":"2019","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ctro.2021.12.002_b0140","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/bjc.2016.386","article-title":"Blood transfusion during radical chemo-radiotherapy does not reduce tumour hypoxia in squamous cell cancer of the head and neck","volume":"116","author":"Welsh","year":"2017","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ctro.2021.12.002_b0145","doi-asserted-by":"crossref","unstructured":"Lambin P, Ramaekers BL, van Mastrigt GA, et al: Erythropoietin as an adjuvant treatment with (chemo) radiation therapy for head and neck cancer. Cochrane Database Syst Rev. 8;(3):CD006158, 2009.","DOI":"10.1002\/14651858.CD006158.pub2"},{"issue":"9392","key":"10.1016\/j.ctro.2021.12.002_b0150","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(03)14567-9","article-title":"Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial","volume":"362","author":"Henke","year":"2003","journal-title":"Lancet"},{"issue":"9674","key":"10.1016\/j.ctro.2021.12.002_b0155","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/S0140-6736(09)60502-X","article-title":"Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials","volume":"373","author":"Bohlius","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ctro.2021.12.002_b0160","doi-asserted-by":"crossref","unstructured":"Bohlius J, Bohlke K, Castelli R, et al: Management of Cancer-Associated Anemia With Erythropoiesis-Stimulating Agents: ASCO\/ASH Clinical Practice Guideline Update. J Clin Oncol. 20;37(15):1336-1351, 2019.","DOI":"10.1200\/JCO.18.02142"},{"key":"10.1016\/j.ctro.2021.12.002_b0165","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.blre.2007.07.003","article-title":"Transfusion-related immunomodulation (TRIM): an update","volume":"21","author":"Vamvakas","year":"2007","journal-title":"Blood Rev"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630821001014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630821001014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:08:22Z","timestamp":1762502902000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630821001014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":33,"alternative-id":["S2405630821001014"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2021.12.002","relation":{},"ISSN":["2405-6308"],"issn-type":[{"type":"print","value":"2405-6308"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of red blood cell transfusion on mortality and treatment efficacy in patients treated with radiation: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2021.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}]}}